Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma ; volume:13 ; number:1 ; day:29 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (29.10.2022), 1-17, 12.2022
- Urheber
-
Tomaszewski, William H.
Waibl-Polania, Jessica
Chakraborty, Molly
Perera, Jonathan
Ratiu, Jeremy
Miggelbrink, Alexandra
McDonnell, Donald P.
Khasraw, Mustafa
Ashley, David M.
Fecci, Peter E.
Racioppi, Luigi
Sanchez-Perez, Luis
Gunn, Michael D.
Sampson, John H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-34175-y
- URN
-
urn:nbn:de:101:1-2023011409255147681195
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tomaszewski, William H.
- Waibl-Polania, Jessica
- Chakraborty, Molly
- Perera, Jonathan
- Ratiu, Jeremy
- Miggelbrink, Alexandra
- McDonnell, Donald P.
- Khasraw, Mustafa
- Ashley, David M.
- Fecci, Peter E.
- Racioppi, Luigi
- Sanchez-Perez, Luis
- Gunn, Michael D.
- Sampson, John H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Activation of phagocytosis by immune checkpoint blockade
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer
Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Activation of phagocytosis by immune checkpoint blockade
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer
Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Activation of phagocytosis by immune checkpoint blockade
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer